OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 1 filers reported holding OPHTHOTECH CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $448,000 | +57.2% | 317,947 | +33.8% | 0.01% | +20.0% |
Q4 2018 | $285,000 | -49.4% | 237,547 | -0.5% | 0.01% | -37.5% |
Q3 2018 | $563,000 | -9.2% | 238,747 | +5.1% | 0.01% | -20.0% |
Q2 2018 | $620,000 | -46.1% | 227,126 | -45.9% | 0.01% | -47.4% |
Q1 2018 | $1,150,000 | -21.9% | 419,844 | -11.0% | 0.02% | -26.9% |
Q4 2017 | $1,472,000 | +196.2% | 471,776 | +167.9% | 0.03% | +160.0% |
Q3 2017 | $497,000 | +291.3% | 176,076 | +569.2% | 0.01% | +400.0% |
Q4 2016 | $127,000 | -40.4% | 26,310 | +422.0% | 0.00% | -60.0% |
Q1 2016 | $213,000 | -90.0% | 5,040 | -81.4% | 0.01% | -88.1% |
Q4 2015 | $2,132,000 | +39.9% | 27,150 | -27.8% | 0.04% | +35.5% |
Q3 2015 | $1,524,000 | +41.5% | 37,610 | +81.9% | 0.03% | +55.0% |
Q2 2015 | $1,077,000 | +67.2% | 20,680 | +49.4% | 0.02% | +81.8% |
Q1 2015 | $644,000 | -7.9% | 13,840 | -11.2% | 0.01% | -8.3% |
Q4 2014 | $699,000 | – | 15,580 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |